EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Flunarizine Pharmacology and Migraine Prevention in Children and Adolescents: A Systematic Review

Luigi Francesco Iannone, Lisa Paiusco, Marina Romozzi, Elisabetta Pelos, Veronica Buratti, Fabio Tascedda, Irene Toldo

Life · 12.11.2026 · 16 (11) · 1913

DOI: 10.3390/life16111913 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Life, online erschienen am 12.11.2026. Verfasst von Luigi Francesco Iannone und 6 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flunarizine is used for migraine prevention in children and adolescents, yet its pharmacological basis in children remains poorly defined. We systematically searched PubMed, Embase, Scopus, and reference lists for original pharmacological studies relevant to migraine and clinical studies involving patients aged 18 years or younger. Findings were synthesized narratively, prioritizing pharmacology. Of 2019 identified records, 62 reports were included (47 pharmacological and 15 pediatric clinical reports) comprising four randomized trials and 11 nonrandomized studies. Very few studies were conducted to explore the pharmacological proprieties of flunarizine in children and adolescents, with none dedicated to migraine. Experimental studies demonstrate preparation-dependent inhibition of neuronal calcium and sodium currents, attenuation of changes associated with cortical spreading depolarization, and suppression of trigeminocervical neuronal responses. Dopaminergic and histaminergic interactions may contribute to adverse effects, but target engagement at pediatric preventive doses remains unknown. Small placebo-controlled trials suggest reduced migraine attack frequency whereas active-comparator trials and observational studies do not establish comparative superiority. Somnolence, weight gain, and mood changes are the principal reported tolerability concerns, while long-term safety remains insufficiently characterized. Flunarizine has a plausible multimodal rationale for migraine prevention in children and adolescents, but pediatric pharmacokinetic and exposure-response studies are needed to connect experimental findings with clinical benefit and risk.

Zitieren

APA

Iannone, L. F., Paiusco, L., Romozzi, M., Pelos, E., Buratti, V., Tascedda, F., & Toldo, I. (2026). Flunarizine Pharmacology and Migraine Prevention in Children and Adolescents: A Systematic Review. Life, 16(11), 1913. https://doi.org/10.3390/life16111913

Vancouver

Iannone LF, Paiusco L, Romozzi M, Pelos E, Buratti V, Tascedda F, et al. Flunarizine Pharmacology and Migraine Prevention in Children and Adolescents: A Systematic Review. Life. 2026;16(11):1913. doi:10.3390/life16111913

BibTeX
@article{Iannone2026,
  author = {Iannone, Luigi Francesco and Paiusco, Lisa and Romozzi, Marina and Pelos, Elisabetta and Buratti, Veronica and Tascedda, Fabio and Toldo, Irene},
  title = {Flunarizine Pharmacology and Migraine Prevention in Children and Adolescents: A Systematic Review},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1913},
  doi = {10.3390/life16111913}
}
Kostenlos starten →